zb19812013 Welcome to the $ONCS MB. What is being assessed now is the book value of $ONCS and its association with MRK's FDA approved check inhibitor Keytruda. Dr. Pierce, $ONCS CSO and former MRK senior R&D Clinical Investigator believes that the Combo of $ONCS EP + IL-12 + Keytruda will have a higher healing response rate vs either Keytruda alone or EP+IL-12 alone.
If the results show that the Combo has a higher healing rate, then there is no limit to $ONCS PPS.